- Companies
- Shields Health Solutions
Shields Health Solutions Acquisition, Valuation, Funding & Investors
Shields Health Solutions was acquired by Sycamore Partners in September 2025.
Shields Health Solutions acquisition price
Undisclosed
Acquired by Sycamore Partners · Sep 2025
Cumulative funding Shields Health Solutions raised
$3.5B
across 1 funding round
Key investors in Shields Health Solutions
Evernorth
About Shields Health Solutions
Shields Health Solutions is a specialty pharmacy accelerator that helps hospitals and health systems build and manage their own specialty pharmacies for patients with complex chronic conditions. It partners with roughly 80 health systems across more than 1,000 hospitals and clinics in nearly every U.S. state, serving more than 7 million patients across over 30 integrated disease states, with access to more than 80% of limited-distribution drugs and payers. Spun out as a standalone company after Sycamore Partners' 2025 buyout of Walgreens Boots Alliance, Shields had previously been a Walgreens subsidiary.
Founded
2012
HQ
Website
Status
Acquired
Customer focus
B2B
Revenue model
Services
Shields Health Solutions Acquisition
Shields Health Solutions was acquired by Sycamore Partners for an undisclosed price on 2 September 2025.
Before the acquisition Shields Health Solutions had raised $3.5B across 1 funding round.
Shields Health Solutions, the premier specialty pharmacy accelerator, helps health systems develop and manage specialty pharmacies for complex chronic conditions, partnering with 80 health systems nationwide across more than 1,000 hospitals and clinics in nearly all 50 states, serving over 7 million patients in 30+ integrated disease states. Sycamore Partners, a New York-based private equity firm with $11 billion in committed capital specializing in consumer, retail, and distribution investments, acquired Shields from Walgreens Boots Alliance (WBA), whose buyout by Sycamore closed on August 28, 2025, establishing Shields as a private standalone company. The acquisition occurred in partnership with Stefano Pessina and his family, who reinvested 100% of their interests, with financing via privately-placed debt from HPS Investment Partners, Goldman Sachs Alternatives, and J.P. Morgan, plus preferred stock from Evernorth Health Services, a Cigna Group subsidiary. The deal enables Shields to accelerate its health system-focused strategy amid rising demand for specialty pharmacy expertise, as stated by CEO Michael Ham and Sycamore's Stefan Kaluzny, who highlighted alignment in patient care commitment. Evernorth's $3.5 billion preferred stock investment, advised regulatorily by Holland & Knight and announced September 2, 2025, provides options for future additional investments without materially impacting Cigna's 2025 adjusted EPS guidance of at least $29.60, enhancing continuity of care across settings. This transaction follows WBA's restructuring into standalone entities including Shields, preserving brands and relationships in a market with increasing medication complexity and costs.
| Acquirer | Date | Type |
|---|---|---|
| 2 Sep 2025 | PE buyout |
Shields Health Solutions Funding History
Shields Health Solutions has raised a total of $3.5B across 1 funding round.
Shields Health Solutions funding rounds
| Date | Stage | Investors | Raised | Deal Summary |
|---|---|---|---|---|
| Sep 2025 | Strategic investment | Evernorth (lead) | $3.5B | Shields Health Solutions is a leading specialty pharmacy management company that helps hospitals and health systems develop and manage their own specialty pharmacies, partnering with over 80 health systems comprising more than 1,000 hospitals and clinics across nearly all 50 U.S. states. The company was spun out as a standalone entity following Sycamore Partners' acquisition of Walgreens in August 2025. On September 2, 2025, Evernorth Health Services, a Cigna Group subsidiary, announced a $3.5 billion investment in Shields in the form of preferred stock, which does not confer a controlling stake but provides optionality for future investments. This move enhances Evernorth's integration with health systems for specialty care delivery amid rising demand for complex therapies. Shields' platform provides access to over 80% of limited distribution drugs and payers, with a clinical model demonstrated to lower total cost of care by 13%. |
Who has invested in Shields Health Solutions?
1 investor has backed Shields Health Solutions across its funding rounds, including Evernorth.
Lead investors include Evernorth.
Shields Health Solutions Investors
| Investor | HQ | Rounds | Role | First check |
|---|---|---|---|---|
This data is available for Pro users. Sign up to see all 1 Shields Health Solutions investors. Start Free Trial | ||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialShields Health Solutions Competitors
Shields Health Solutions competitors include listed companies like Craneware and Waystar, and private ones like Cohere Health, Pearl Health, Clari and Judi Health.
| Company | HQ | Status | Revenue | EBITDA | Valuation | Revenue Multiple |
|---|---|---|---|---|---|---|
| Private | - | - | $750M | - | ||
| Private | - | - | $733M | - | ||
| Private | - | - | $2.6B | - | ||
| Publicly listed | $206M | $59M | $589M | 2.7x | ||
| Private | - | - | $3.3B | - | ||
| Publicly listed | $1.1B | $390M | $5.1B | 5.2x |
Shields Health Solutions Public Comps
Shields Health Solutions is no longer listed, but its public comps include Craneware, CareCloud, MSP Recovery, Waystar and Tenet Healthcare.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $206M | $59M | 2.8x | 2.7x | 9.7x | 8.7x | |||
| $120M | $28M | 1.1x | 1.1x | 4.8x | 5.0x | |||
| $18M | ($1.1B) | 33.4x | - | (0.5x) | - | |||
This data is available for Pro users. Sign up to see all Shields Health Solutions competitors and their valuation data. Start Free Trial | ||||||||
Common questions about Shields Health Solutions
| When was Shields Health Solutions founded? | Shields Health Solutions was founded in 2012. |
| Where is Shields Health Solutions headquartered? | Shields Health Solutions is headquartered in United States. |
| Is Shields Health Solutions publicly listed? | No, Shields Health Solutions was acquired by Sycamore Partners in September 2025. |
| Who acquired Shields Health Solutions? | Shields Health Solutions was acquired by Sycamore Partners in September 2025. |
| How much funding has Shields Health Solutions raised? | Shields Health Solutions has raised $3.5B across 1 funding round. |
| What was Shields Health Solutions' last funding round? | Shields Health Solutions' last funding round was a $3.5B strategic investment round in September 2025, led by Evernorth. |
| Who are Shields Health Solutions' investors? | Shields Health Solutions' investors include Evernorth. |
| Which companies are comparable to Shields Health Solutions? | Companies comparable to Shields Health Solutions include Cohere Health, Pearl Health, Clari, Craneware, Judi Health and Waystar. |
See companies similar to Shields Health Solutions
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




